Nonalbuminuric Renal Insufficiency in Type 2 Diabetes

  1. Richard J. MacIsaac, PHD, MBBS, FRACP12,
  2. Con Tsalamandris, MBBS12,
  3. Sianna Panagiotopoulos, BSC (HONS), PHD1,
  4. Trudy J. Smith, BSC, MAPPSC1,
  5. Karen J. McNeil, MBBS1 and
  6. George Jerums, MBBS, FRACP, MD12
  1. 1Endocrinology Unit, Austin Health, Heidelberg, Victoria, Australia
  2. 2Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
  1. Address correspondence and reprint requests to Dr. R.J. MacIsaac, Endocrinology Unit, Austin Health, Heidelberg, Victoria, 3084, Australia. E-mail: r.macisaac{at}austin.unimelb.edu.au

Abstract

OBJECTIVE—To determine the prevalence and characteristics of patients with type 2 diabetes who have impaired renal function, defined as a glomerular filtration rate (GFR) <60 ml · min−1 · 1.73 m−2, and normoalbuminuria.

RESEARCH DESIGN AND METHODS—A cross-sectional survey of 301 outpatients attending a single tertiary referral center using the plasma disappearance of isotopic 99mTc-diethylene-triamine-penta-acetic acid to measure GFR and at least two measurements of urinary albumin excretion rate (AER) over 24 h to determine albuminuria.

RESULTS—A total of 109 patients (36%) had a GFR <60 ml · min−1 · 1.73 m−2. The overall prevalence of normo-, micro-, and macroalbuminuria was 43 of 109 (39%), 38 of 109 (35%), and 28 of 109 (26%), respectively. Compared with patients with macroalbuminuria, those with normoalbuminuria were more likely to be older and female. After excluding patients whose normoalbuminuric status was possibly related to the initiation of a renin-angiotensin system (RAS) inhibitor before the start of the study, the prevalence of a GFR <60 ml · min−1 · 1.73 m−2 and normoalbuminuria was 23%. Temporal changes in GFR in a subset of 34 of 109 (32%) unselected patients with impaired renal function were available for comparison over a 3- to 10-year period. The rates of decline in GFR (ml · min−1 · 1.73 m−2 · year−1) of −4.6 ± 1.0, −2.8 ± 1.0, and −3.0 ± 07 were not significantly different for normo- (n = 12), micro- (n = 12), and macroalbuminuric (n = 10) patients, respectively.

CONCLUSIONS—These results suggest that patients with type 2 diabetes can commonly progress to a significant degree of renal impairment while remaining normoalbuminuric.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted October 5, 2003.
    • Received March 11, 2003.
« Previous | Next Article »Table of Contents